 larynx preserv combin chemotherapi radiat therapi advanc resect head neck cancer patient advanc resect squamou cell carcinoma larynx oropharynx hypopharynx surgeri total laryngectomi TL cycl cisplatin-bas chemotherapi local therapi goal larynx preserv clinic complet respons cr partial respons pr patient patient primary-sit diseas unrespons underw resect primari lesion neck dissect radiat therapi RT thirty-seven patient chemotherapi RT neck dissect patient disease-fre evid diseas ned median follow-up month rang overal actuari surviv rate group year year failure-fre surviv rate year seven patient TL cours surviv result proport patient CR PR disease-fre PR sixteen patient locoregion diseas patient underw TL initi induct failur relaps actual larynx-preserv rate patient patient TL anticip preserv rate patient larynx preserv combin chemotherapi radiat feasibl effect patient advanc resect squamou cell carcinoma head neck schn treatment approach motiv patient care patient monitor interdisciplinari cooper oncologist